![Géraldine Honnet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Géraldine Honnet is currently the Chief Medical Officer at Sensorion SA since 2020.
Prior to this, she worked as the Director-Development at Genethon from 2017 to 2020, as a Senior Clinical Manager at Transgene SA from 2007 to 2011, and as a Medical Director at PAREXEL International Corp.
from 2001 to 2005.
Posizioni attive di Géraldine Honnet
| Società | Posizione | Inizio |
|---|---|---|
| SENSORION | Direttore Tecnico/Scientifico/R&S | 18/02/2020 |
Precedenti posizioni note di Géraldine Honnet
| Società | Posizione | Fine |
|---|---|---|
Genethon
 Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Corporate Officer/Principal | 01/01/2020 |
| TRANSGENE | Corporate Officer/Principal | 01/04/2011 |
| PAREXEL INTERNATIONAL CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/09/2005 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
25
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
